Impact of Uncontrolled vs Controlled Rate Freeze-Thaw Technologies on Process Performance and Product Quality

References

1. 1.↵
   1. Webb S. D.,
   2. Webb J. N.,
   3. Hughes T. G.,
   4. Sesin D. F.,
   5. Kincaid A. C.

   Freezing biopharmaceutical using common techniques—and the magnitude of bulk scale freeze-concentration. Biopharm 2002, 15 (5), 22–34

   OpenUrl
2. 2.↵
   1. Lashmar U. T.,
   2. Vnanderburgh M.,
   3. Little S. J.

   Bulk freeze-thaw of macromolecules: effect of cryoconcentration on their formulation and stability. BioProcess Int. 2007, 5 (6), 44–54

   OpenUrl
3. 3.↵
   1. Glaser V.

   Addressing stability of biological drugs. Gen. Eng. Biotechnol. News 2005, 25 (6)
4. 4.↵
   1. Pikal-Cleland K. A.,
   2. Cleland J. L.,
   3. Anchordoquy T. J.,
   4. Carpenter J. F.

   Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems. J. Pharm. Sci. 2002, 91 (9), 1969–1979

   OpenUrlPubMed
5. 5.↵
   1. Strambini G. B.,
   2. Gabellieri E.

   Protein in frozen solutions: evidence of ice-induced partial unfolding. Biophys. J. 1996, 70 (2), 971–976

   OpenUrlPubMed
6. 6.↵
   1. Cao E.,
   2. Chen Y.,
   3. Cui Z.,
   4. Foster P. R.

   Effect of freezing and thawing rates on denaturation of protein in aqueous solutions. Biotechnol. Bioeng. 2003, 82 (6), 684–690

   OpenUrlPubMed
7. 7.↵
   1. Hsu C. C.,
   2. Nguyen H. M.,
   3. Yeung D. A.,
   4. Brooks D. A.,
   5. Koe G. S.,
   6. Bewley T. A.,
   7. Pearlman R.

   Surface denaturation at solid-void interface—a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures. Pharm. Res. 1995, 12 (1), 69–77

   OpenUrlPubMed
8. 8.↵
   1. Privalov P. L.

   Cold denaturation of proteins. Crit. Rev. Biochem. Mol. Biol. 1990, 25 (4), 281–305

   OpenUrlPubMedWeb of Science
9. 9.↵
   1. Jayachithra K.,
   2. Kumar T. K. S.,
   3. Lu T.,
   4. Yu C.,
   5. Chin D.

   Cold instability of aponeocarzinostatin and its stabilization by labile chromophore. Biophys. J. 2005, 88 (6), 4252–4261

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Antonino L. C.,
    2. Kautz R. A.,
    3. Nakano T.,
    4. Fox R. O.,
    5. Fink A. L.

    Cold denaturation and 2H2O stabilization of a staphylococcal nuclease mutant. Proc. Natl. Acad. Sci. 1991, 88 (17), 7715–7718

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Wilkins J.,
    2. Sesin D.,
    3. Wisniewski R.

    Large-scale cryopreservation of bio-therapeutic products. Innov. Pharm. Technol. 2001, 8, 174
12. 12.↵
    1. Voute N.,
    2. Dooley T.,
    3. Peron G.,
    4. Lee E.

    Disposable technology for controlled freeze-thaw. BioProcess Int. 2004, Supplement, 40–43.